Sanochemia is to contribute to the security of supply of pharmaceuticals in the future. According to Thomas Erkinger, this requires a pharmaceutical strategy from policymakers that involves small and medium-sized enterprises. A first targeted step would be to promote the very expensive qualification and approval processes for Austrian manufacturers. In an interview with Trend, the CEO of EOSS and Sanochemia also talks about the strength of the innovation orientation of the technology company EOSS and how the latest addition Sanochemia will succeed in becoming a successful Austrian player in the pharmaceutical market after the Corona crisis. // 05.2020 Trend
